During the last three months, 10 analysts shared their evaluations of Kenvue KVUE, revealing diverse outlooks from bullish to bearish. The table below provides a concise overview of recent ratings ...

Kenvue, Inc. is a consumer health company. It operates through the following business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold ...

SKILLMAN, N.J. (AP) — SKILLMAN, N.J. (AP) — Kenvue Inc. (KVUE) on Thursday reported third-quarter profit of $383 million. On a per-share basis, the Skillman, New Jersey-based company said it ...

Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment ...

Johnson & Johnson's spun off company Kenvue (NYSE:KVUE) just received investment from activist investment firm Starboard Value LP. And the investment will add more capital to Kenvue to further its ...

Kenvue, Inc. (KVUE – Research Report), the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Anna Lizzul from Bank of America Securities reiterated a Buy ...

Kenvue said it now expects annual net sales to grow closer to the lower end of its forecast of 1% to 3% growth. It reaffirmed its annual per share profit forecast of between $1.10 and $1.20.

(Reuters) -Neutrogena-owner Kenvue's third-quarter sales fell short of expectations on Thursday, marking the fifth consecutive quarter of year-over-year decline in its core skin health and beauty ...